Demystifying serotonin syndrome (or serotonin toxicity)
- PMID: 30315014
- PMCID: PMC6184959
Demystifying serotonin syndrome (or serotonin toxicity)
Abstract
Objective: To review the symptoms of serotonin toxicity (commonly referred to as serotonin syndrome) and the causative drugs and their mechanisms of action, and to equip primary care providers with practical strategies to prevent and identify serotonin toxicity.
Quality of evidence: PubMed and Google Scholar were searched for relevant articles on serotonin toxicity, the causes, and the differential diagnosis using search terms related to serotonin toxicity (serotonin syndrome, serotonin toxicity, serotonin overdose), causes (individual names of drug classes, individual drug names), and diagnosis (differential diagnosis, neuroleptic malignant syndrome, anticholinergic toxicity, discontinuation syndrome, malignant hyperthermia, serotonin symptoms). Experts in psychiatric medicine, psychiatric pharmacy, clinical pharmacology, and medical toxicology were consulted. Evidence is level II and III.
Main message: Serotonin toxicity is a drug-induced condition caused by too much serotonin in synapses in the brain. Cases requiring hospitalization are rare, and mild cases caused by serotonin-mediated side effects are unlikely to be fatal. Patients present with a combination of neuromuscular, autonomic, and mental status symptoms. Serotonin-elevating drugs include monoamine oxidase inhibitors, serotonin reuptake inhibitors, and serotonin releasers. Most cases involve 2 drugs that increase serotonin in different ways; the most concerning combination is a monoamine oxidase inhibitor with a selective serotonin reuptake inhibitor or a serotonin-norepinephrine reuptake inhibitor.
Conclusion: Family physicians play a key role in identifying and preventing serotonin syndrome by teaching patients to recognize symptoms and monitoring patients throughout therapy.
Copyright© the College of Family Physicians of Canada.
Figures
Similar articles
-
The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes.Clin Toxicol (Phila). 2022 Feb;60(2):143-158. doi: 10.1080/15563650.2021.1993242. Epub 2021 Nov 22. Clin Toxicol (Phila). 2022. PMID: 34806513 Review.
-
Recognizing serotonin toxicity in the pediatric emergency department.Pediatr Emerg Care. 2012 Aug;28(8):817-21; quiz 822-4. doi: 10.1097/PEC.0b013e31826289d9. Pediatr Emerg Care. 2012. PMID: 22863827 Review.
-
The serotonin syndrome.Neth J Med. 2004 Oct;62(9):309-13. Neth J Med. 2004. PMID: 15635814 Review.
-
The serotonin syndrome.N Engl J Med. 2005 Jun 9;352(23):2454-6; author reply 2454-6. N Engl J Med. 2005. PMID: 15948272 No abstract available.
-
The serotonin syndrome.N Engl J Med. 2005 Mar 17;352(11):1112-20. doi: 10.1056/NEJMra041867. N Engl J Med. 2005. PMID: 15784664 Review. No abstract available.
Cited by
-
Recognizing serotonin syndrome in the intensive care unit: a case report of serotonin syndrome in a patient taking amitriptyline, buprenorphine, pregabalin, and fentanyl.AME Case Rep. 2024 Aug 13;8:97. doi: 10.21037/acr-24-40. eCollection 2024. AME Case Rep. 2024. PMID: 39380866 Free PMC article.
-
Predictors of Serotonin Syndrome in Acute Poisoning with 5-Hydroxytryptamine Modulators.Toxics. 2024 Jul 30;12(8):550. doi: 10.3390/toxics12080550. Toxics. 2024. PMID: 39195652 Free PMC article.
-
Multipronged Electronic Health Record Analysis of Antidepressant Effectiveness on Depression Remission in Patients With Concurrent Depression and Irritable Bowel Syndrome.Cureus. 2024 Jul 20;16(7):e64968. doi: 10.7759/cureus.64968. eCollection 2024 Jul. Cureus. 2024. PMID: 39161523 Free PMC article.
-
Ecstasy-Induced Rhabdomyolysis Leading to Severe Acute Kidney Injury Requiring Temporary Hemodialysis: A High Risk for Recurrence With Repeated Exposure.Cureus. 2024 Jul 7;16(7):e64010. doi: 10.7759/cureus.64010. eCollection 2024 Jul. Cureus. 2024. PMID: 39109110 Free PMC article.
-
Acute clomipramine exposure elicits dose-dependent surfacing behavior in adult zebrafish (Danio rerio).PeerJ. 2024 Jul 19;12:e17803. doi: 10.7717/peerj.17803. eCollection 2024. PeerJ. 2024. PMID: 39040938 Free PMC article.
References
-
- Dunkley EJC, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635–42. - PubMed
-
- Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112–20. Errata in: N Engl J Med 2007;356(23):2437, N Engl J Med 2009;361(17)1714. - PubMed
-
- Gillman PK. A review of serotonin toxicity data: implication for the mechanisms of antidepressant drug action. Biol Psychiatry. 2006;59(11):1046–51. Epub 2006 Feb 7. - PubMed
-
- Gillman PK. Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review. Headache. 2010;50(2):264–72. Epub 2009 Nov 17. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials